Cannabidiol News June 3, 2020
Leaping Bunny accreditation assures consumers that products are cruelty-free cosmetics from a Company supporting animal-free products, like Sweet Earth. Accreditation requires the final product to be cruelty-free. Many companies brand themselves as cruelty-free but still use raw materials that have been tested on animals; Sweet Earth assures its customers that all its production, in addition to being organic are 100% animal friendly.
Long Beach, Calif., June 02, 2020 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced that the company’s proprietary analog of cannabidiol, cannabidiol-valine-hemisuccinate (CBDVHS) has been awarded a patent in Japan that covers composition of matter claims and multiple methods of use. This molecule, licensed from the University of Mississippi, was recently granted a similar patent in the United States.
CBDVHS has been successfully formulated for ocular use and in pre-clinical animal studies, has been shown to enter all chambers of the eye, potentially making this molecule a strong therapeutic candidate for diseases of the retina like macular degeneration and diabetic retinopathy. Animal studies of the painful chemotherapy-induced peripheral neuropathy (CIPN) syndrome, demonstrated CBDVHS possessed an analgesic effect comparable to morphine, as well as an anti-addictive profile, making the molecule a potential safer alternative to opioids in managing pain. CBDVHS was reviewed and deemed not to be a controlled substance by the Drug Enforcement Agency (DEA) in 2019.
Federally Funded Marijuana Turns 50
Leafly’s article points to The CBD Store as a choice for consumers in buying CBD Online. Thanks, Leafly!
Brought to you by The CBD Store Seattle WA
Scott Salisbury Owner